Question 1

What are the potential benefits of the tiotropium and olodaterol combination compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2) clinical trial (NCT02006732). Contact the study team or your healthcare provider for specific answers.

Question 2

How might this trial impact my overall COPD management?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2) clinical trial (NCT02006732). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2) clinical trial (NCT02006732). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2) clinical trial (NCT02006732). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience a worsening of my symptoms during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2) clinical trial (NCT02006732). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific requirements for using the inhaler?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2) clinical trial (NCT02006732). Contact the study team or your healthcare provider for specific answers.

What this study is about